Trial Profile
A phase 1 study of Resunab in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2017
Price :
$35
*
At a glance
- Drugs Lenabasum (Primary) ; Prednisolone
- Indications Cystic fibrosis; Scleroderma
- Focus Adverse reactions; Pharmacokinetics
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 28 Sep 2016 According to Corbus Pharmaceticals media release, data from this study was presented at 6th European Workshop on Lipid Mediators at Goethe University in, Germany.
- 28 Sep 2016 Results were published in Corbus Pharmaceuticals Media Release.